Your browser doesn't support javascript.
loading
Duration and severity of symptoms and levels of plasma interleukin-1 receptor antagonist, soluble tumor necrosis factor receptor, and adhesion molecules in patients with common cold treated with zinc acetate.
Prasad, Ananda S; Beck, Frances W J; Bao, Bin; Snell, Diane; Fitzgerald, James T.
Afiliación
  • Prasad AS; Department of Internal Medicine, Wayne State University School of Medicine, Detroit, MI 48201, USA. prasada@karmanos.org
J Infect Dis ; 197(6): 795-802, 2008 Mar 15.
Article en En | MEDLINE | ID: mdl-18279051
BACKGROUND: Zinc lozenges have been used for treatment of the common cold; however, the results remain controversial. METHODS: Fifty ambulatory volunteers were recruited within 24 h of developing symptoms of the common cold for a randomized, double-blind, placebo-controlled trial of zinc. Participants took 1 lozenge containing 13.3 mg of zinc (as zinc acetate) or placebo every 2-3 h while awake. The subjective scores for common cold symptoms were recorded daily. Plasma zinc, soluble interleukin (IL)-1 receptor antagonist (sIL-1ra), soluble tumor necrosis factor receptor 1, soluble vascular endothelial cell adhesion molecule, and soluble intercellular adhesion molecule (sICAM)-1 were assayed on days 1 and 5. RESULTS: Compared with the placebo group, the zinc group had a shorter mean overall duration of cold (4.0 vs. 7.1 days; P < .0001) and shorter durations of cough (2.1 vs. 5.0 days; P < .0001) and nasal discharge (3.0 vs. 4.5 days, P = .02) Blinding of subjects was adequate, and adverse effects were comparable in the 2 groups. Symptom severity scores were decreased significantly in the zinc group. Mean changes in plasma levels of zinc, sIL-1ra, and ICAM-1 differed significantly between groups. CONCLUSION: Administration of zinc lozenges was associated with reduced duration and severity of cold symptoms. We related the improvement in cold symptoms to the antioxidant and anti-inflammatory properties of zinc.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Receptores del Factor de Necrosis Tumoral / Resfriado Común / Molécula 1 de Adhesión Intercelular / Acetato de Zinc / Proteína Antagonista del Receptor de Interleucina 1 Tipo de estudio: Clinical_trials / Diagnostic_studies Límite: Adult / Female / Humans / Male Idioma: En Revista: J Infect Dis Año: 2008 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Receptores del Factor de Necrosis Tumoral / Resfriado Común / Molécula 1 de Adhesión Intercelular / Acetato de Zinc / Proteína Antagonista del Receptor de Interleucina 1 Tipo de estudio: Clinical_trials / Diagnostic_studies Límite: Adult / Female / Humans / Male Idioma: En Revista: J Infect Dis Año: 2008 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos